Histone Deacetylase Inhibitors and Anticancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 4, 2002-07 ,pp. : 477-484

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo

By                  

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 451-458

Spandidos Publications

Access to resources Recommend Favorite

The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells

By Groh Tomas   Hrabeta Jan   Khalil Mohammed Ashraf   Doktorova Helena   Eckschlager Tomas   Stiborova Marie  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-07 ,pp. : 343-352

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines

By García-López Patricia   Rodríguez-Dorantes Mauricio   Pérez-Cárdenas Enrique   Cerbón Marco   Mohar-Betancourt Alejandro  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 533-540

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

By Fang Yong   Hu Yi   Wu Peng   Wang Beibei   Tian Yuan   Xia Xi   Zhang Qinghua   Chen Tong   Jiang Xuefeng   Ma Quanfu   Xu Gang   Wang Shixuan   Zhou Jianfeng   Ma Ding   Meng Li  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite